William Hoffman, Director at Inari Medical, Inc. (NARI), sold 49,300 shares at $69.53 ($3.4M) on 2023-08-15, disclosed to the SEC on 2023-08-17.
Scheduled sale ($3.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.61 | 8,964 | $615K | 18.1% |
| 2 | $68.61 | 8,964 | $615K | 18.1% |
| 3 | $68.66 | 6,192 | $425K | 12.5% |
| 4 | $68.66 | 6,192 | $425K | 12.5% |
| 5 | $69.52 | 5,636 | $392K | 11.5% |
| 6 | $69.52 | 5,636 |
| $392K |
| 11.5% |
| 7 | $69.53 | 3,508 | $244K | 7.2% |
| 8 | $69.53 | 3,508 | $244K | 7.2% |
| 9 | $70.92 | 300 | $21K | 0.6% |
| 10 | $70.93 | 400 | $28K | 0.8% |
| Total | $68.99 avg | 49,300 | $3.4M | 100% |
| Filing → |
| NARI | SELL | 2024-11-20 | $5.5M | — | Filing → |
| NARI | SELL | 2024-10-31 | $2.0M | — | Filing → |
| NARI | SELL | 2024-10-18 | $3.6M | — | Filing → |